Finance

Lists
Why is 4TZ up 2,94%?
Dive Deeper
4TZ:FRA
ORIC Pharmaceuticals Inc
10,50 €
+2,94%
(+0,30) 1D
9-окт., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4TZ...
Open
10,54 €
High
10,54 €
Low
10,50 €
Mkt. cap
1,24 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
12,32 €
52-wk low
6,10 €
No. of employees
111
Open
10,54 €
High
10,54 €
Low
10,50 €
Mkt. cap
1,24 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
12,32 €
52-wk low
6,10 €
No. of employees
111
News stories
From web sources and news partners
About ORIC Pharmaceuticals Inc
CEO-
Employees111
Founded2014
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28,77 млн
25,86 млн
31,44 млн
36,30 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,90 млн
8,70 млн
8,18 млн
9,00 млн
Operating expense
36,67 млн
34,55 млн
39,62 млн
45,30 млн
Total operating expenses
36,67 млн
34,55 млн
39,62 млн
45,30 млн
Operating income
-36,67 млн
-34,55 млн
-39,62 млн
-45,30 млн
Other non operating income
-
-
-
-
EBT including unusual items
-32,59 млн
-30,50 млн
-35,77 млн
-41,49 млн
EBT excluding unusual items
-32,59 млн
-30,50 млн
-35,77 млн
-41,49 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32,59 млн
-30,50 млн
-35,77 млн
-41,49 млн
Net profit margin
-
-
-
-
Earnings per share
-0,33
-0,30
-0,34
-0,38
Interest and investment income
4,08 млн
4,05 млн
3,85 млн
3,80 млн
Interest expense
-
-
-
-
Net interest expenses
4,08 млн
4,05 млн
3,85 млн
3,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,38 млн
-34,23 млн
-39,35 млн
-45,03 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору